Drugs and Alcohol Abuse — Pharmacology, Neuroscience, and Health

• Classification of psychoactive drugs: opioids, cannabinoids, stimulants, depressants, hallucinogens
• Neurochemical mechanisms — dopamine reward pathway, receptor pharmacology
• How tobacco and alcohol damage organ systems
• Distinction between addiction (psychological dependence) and physical dependence
• Key drug sources (plant/chemical), medical vs abused uses

Level 1 — Foundations

Classification of Drugs of Abuse

Opioids

• Medical uses: analgesia (pain relief — post-surgical, cancer pain), antidiarrheal (loperamide — peripheral opioid receptor agonist), cough suppression (codeine)
• Heroin (diacetylmorphine): synthesised from morphine by acetylation; 2–3× more lipid-soluble → crosses blood-brain barrier faster → more intense euphoria → high addiction potential
• Routes: oral (codeine), IV injection (heroin), intranasal (snorting)
• Overdose: triad — pinpoint pupils (miosis), respiratory depression, coma; treated with naloxone (competitive opioid antagonist)

Cannabinoids

• THC: principal psychoactive compound; smoked (ganja/marijuana) or ingested (bhang)
• Effects: euphoria, relaxation, altered time perception, impaired short-term memory (hippocampal CB1 receptors), increased appetite ("munchies" — hypothalamic CB1), dry mouth, red eyes
• Medical uses: nausea in chemotherapy, glaucoma (reduces intraocular pressure), chronic pain, MS spasticity (dronabinol, nabilone)
• Long-term: cannabis use disorder, psychosis risk (especially in adolescents with genetic predisposition)

Cocaine

• Source: coca leaves (chewed traditionally in Andes); cocaine HCl (salt form, water-soluble) for snorting/IV; crack cocaine (freebase, smoked) — faster onset, shorter duration, higher addiction potential
• Local anesthetic: blocks voltage-gated Na⁺ channels in peripheral nerves → used in ENT surgery
• Systemic stimulant: blocks dopamine, norepinephrine, serotonin reuptake transporters
• Acute effects: intense euphoria, tachycardia, hypertension, mydriasis (pupil dilation), vasoconstriction → cardiovascular events (heart attack, stroke even in young users)
• Nasal septum perforation with chronic intranasal use

Tobacco

• Nicotine: primary addictive component; rapid absorption (lungs: 7 sec to brain); half-life ~2 hours
• Tar: mixture of polycyclic aromatic hydrocarbons (PAHs, e.g., benzo[a]pyrene), nitrosamines — carcinogenic; causes lung, oral, esophageal, bladder carcinoma
• Carbon monoxide (CO): binds hemoglobin with ~200× greater affinity than O₂ (forming COHb) → reduced O₂ carrying capacity → hypoxia → compensatory polycythemia (increased RBC production)
• Health consequences: lung cancer (#1 preventable cancer death), COPD (emphysema + chronic bronchitis), cardiovascular disease, peripheral vascular disease, pregnancy complications

Alcohol (Ethanol)

• CNS depressant: enhances GABA_A receptor activity (inhibitory) + inhibits NMDA glutamate receptor (excitatory) → slowed reflexes, sedation, anxiolysis, disinhibition at low doses
• Organ damage: fatty liver (steatosis) → alcoholic hepatitis → cirrhosis (irreversible fibrosis); pancreatitis; gastritis; cardiomyopathy; peripheral neuropathy
• Fetal Alcohol Syndrome (FAS): alcohol crosses placenta → most common preventable cause of intellectual disability; features: growth retardation, microcephaly, characteristic facies (smooth philtrum, thin upper lip, small palpebral fissures), cognitive impairment, behavioral problems
• Blood alcohol concentration (BAC): 0.08% = legal limit in many countries; 0.3%+ = severe impairment; 0.4%+ = potentially lethal (respiratory depression)

Addiction vs Physical Dependence

• Addiction (psychological dependence): compulsive drug-seeking behavior despite negative consequences; driven by craving and reward circuit dysregulation; not always accompanied by physical dependence (e.g., cocaine — powerful psychological dependence, minimal physical withdrawal)
• Physical dependence: adaptation of body to presence of drug → withdrawal symptoms on cessation (opposite of drug effect): opioid withdrawal — diarrhea, vomiting, piloerection ("cold turkey"), myalgia, anxiety, insomnia; alcohol withdrawal — tremors, seizures, delirium tremens; benzodiazepine withdrawal — anxiety, seizures (life-threatening)
• Tolerance: increasing doses needed for same effect; due to receptor downregulation and reduced sensitivity; explains escalating drug use in addiction

Level 2 — JEE / NEET depth

Opioid Receptor Pharmacology

• Opioid receptors: μ (mu), δ (delta), κ (kappa) — all GPCRs (Gi protein coupled → decrease cAMP, open K⁺ channels, close Ca²⁺ channels → hyperpolarization → decreased neuronal firing)
• Endogenous ligands (endorphins): β-endorphin (μ-preferring), enkephalins (μ/δ), dynorphins (κ); produced in hypothalamus, anterior pituitary, limbic system, dorsal horn of spinal cord
• Morphine/heroin: exogenous μ agonists → same euphoria/analgesia pathways as endorphins but longer duration and higher receptor occupancy
• Analgesia: spinal cord dorsal horn (decreased pain signal transmission) + brain (supraspinal analgesia via periaqueductal gray)
• Euphoria: μ receptors on GABAergic interneurons in ventral tegmental area (VTA) → normally GABA inhibits dopamine release → opioids block this inhibition → disinhibition of dopamine neurons → dopamine surge in nucleus accumbens (NAc) → euphoria/reward
• Respiratory depression: μ receptors in brainstem respiratory centers (pre-Bötzinger complex) → most dangerous effect; cause of opioid overdose death

Cannabinoid Receptor Pharmacology

• CB1 receptors: primarily CNS (prefrontal cortex, hippocampus, basal ganglia, cerebellum); GPCR (Gi) → reduce cAMP → presynaptic inhibition (reduce neurotransmitter release)
• CB2 receptors: primarily immune cells and peripheral tissues; role in inflammation modulation
• Endogenous ligand: anandamide (arachidonoylethanolamide — "ananda" = bliss in Sanskrit) and 2-AG (2-arachidonoylglycerol) → both are retrograde messengers (released by postsynaptic cell, act on presynaptic CB1 to reduce release)
• THC: partial agonist at CB1 and CB2; more potent/longer-lasting than anandamide (resists enzymatic degradation by FAAH — fatty acid amide hydrolase)
• Hippocampal CB1 activation → impairs LTP (long-term potentiation) → explains short-term memory impairment with cannabis use

Cocaine Mechanism — Dopamine Transporter Blockade

• Dopaminergic synapse (VTA → NAc): dopamine released into synapse → binds D1/D2 receptors → dopamine transporter (DAT) normally reuptakes dopamine (terminates signal)
• Cocaine: blocks DAT → dopamine accumulates in synapse → prolonged, intense activation of D1/D2 receptors in NAc → intense euphoria ("rush")
• Also blocks NET (norepinephrine transporter) → tachycardia, hypertension, peripheral vasoconstriction; blocks SERT (serotonin transporter) → some mood elevation
• Crash: dopamine depletion post-cocaine → dysphoria, depression, intense craving (drives repeated use)
• Chronic use: D2 receptor downregulation → reduced ability to feel pleasure from natural rewards (food, sex, social interaction) → anhedonia → stronger compulsion to use cocaine

LSD — Serotonin Receptor Agonism

• LSD (d-lysergic acid diethylamide): synthesised from ergotamine; potent partial agonist at 5-HT2A receptors (serotonin receptors) in prefrontal cortex, thalamus, locus coeruleus
• 5-HT2A activation in layer 5 pyramidal neurons of PFC → hallucinations, ego dissolution, altered perception of time/space, synesthesia (senses "cross" — seeing sounds, hearing colors)
• Also agonist at D2 and some other 5-HT subtypes
• No known lethal dose from direct toxicity (deaths from accidents/behavior during intoxication); no physical withdrawal; minimal evidence of addiction (but HPPD — Hallucinogen Persisting Perception Disorder can occur)

MDMA (3,4-methylenedioxymethamphetamine / "Ecstasy")

• Mechanism: reverses SERT, DAT, NET → massive non-vesicular release of serotonin, dopamine, norepinephrine into synapse + blocks reuptake
• Serotonin release dominates → empathy, emotional closeness ("entactogen"), mild euphoria; reduces fear response (amygdala serotonin)
• Risks: hyperthermia (disrupted serotonin thermoregulation + dancing in hot environments → core temp >40°C → rhabdomyolysis, multi-organ failure); hyponatremia (MDMA promotes ADH release + excessive water drinking → dilutional hyponatremia → cerebral edema); serotonin syndrome if combined with MAOIs or SSRIs (hyperthermia, clonus, agitation, autonomic instability)
• Neurotoxicity: repeated high-dose MDMA → serotonergic axon terminal degeneration in cortex and hippocampus (shown in PET and post-mortem human studies)

Tobacco — Molecular Mechanisms

• Nicotine: binds nicotinic acetylcholine receptors (nAChRs) — ligand-gated ion channels (Na⁺/Ca²⁺ influx); most relevant for addiction: α4β2 nAChRs in VTA → dopamine release in NAc (same reward pathway as all addictive drugs)
• Tar: benzo[a]pyrene → cytochrome P450 1A1 (CYP1A1) metabolizes to benzo[a]pyrene diol epoxide (BPDE) → forms DNA adducts at guanine → G→T transversions in TP53 tumor suppressor gene (found in ~60% of lung cancers from smokers)
• CO: carboxyhemoglobin (COHb): oxyhemoglobin dissociation curve shifts LEFT (CO raises Hb O₂ affinity → oxygen not released to tissues = functional anemia despite normal RBC count); also impairs mitochondrial cytochrome oxidase
• Chronic bronchitis: nicotine + irritants → goblet cell hyperplasia → excess mucus; ciliary paralysis (nicotine) → impaired mucociliary clearance → mucus retention → bacterial colonization

Alcohol Metabolism

• Ethanol → Acetaldehyde [enzyme: alcohol dehydrogenase (ADH); NAD⁺ → NADH] → Acetate [enzyme: aldehyde dehydrogenase (ALDH); NAD⁺ → NADH] → CO₂ + H₂O
• NADH accumulation: inhibits gluconeogenesis → hypoglycemia; inhibits fatty acid oxidation → fatty acid accumulation → steatosis (fatty liver); increased lactate (lactic acidosis)
• ALDH2 polymorphism (ALDH2*2 — East Asian "flushing allele"): reduced ALDH2 activity → acetaldehyde accumulates → flushing, tachycardia, nausea (Antabuse-like reaction); acts as natural deterrent to alcohol abuse
• Wernicke-Korsakoff syndrome: thiamine (B1) deficiency in alcoholics (poor diet + impaired absorption) → Wernicke's encephalopathy (confusion, ataxia, ophthalmoplegia) → if untreated → Korsakoff's psychosis (severe anterograde amnesia, confabulation)
• Liver disease progression: steatosis (fatty liver, reversible) → alcoholic steatohepatitis (ASH, inflammation) → fibrosis → cirrhosis (irreversible, portal hypertension, ascites, varices, hepatic encephalopathy, hepatorenal syndrome) → hepatocellular carcinoma risk
• Tolerance mechanism: receptor downregulation — chronic alcohol → downregulation of GABA_A receptors + upregulation of NMDA receptors → CNS hyperexcitability in tolerance state → withdrawal seizures when alcohol stopped (rebound NMDA overactivation)

Explain what happens at the neurological and molecular level when a person snorts cocaine, feels the rush, and then experiences craving:

Step 1 — ADMINISTRATION
Cocaine HCl powder insufflated (snorted) → absorbed through nasal mucosa
→ enters bloodstream → crosses blood-brain barrier within 3–5 minutes
(lipid-soluble enough; faster route: IV ~30 sec, smoking crack ~10 sec)

Step 2 — DAT BLOCKADE IN NUCLEUS ACCUMBENS
In mesolimbic dopamine pathway (VTA → nucleus accumbens, NAc):
Under normal conditions:
  VTA dopamine neuron fires → dopamine released into synapse →
  binds D1/D2 receptors on NAc neurons → signal transduction →
  DAT rapidly clears dopamine from synapse (~200 ms half-life)

With cocaine:
  Cocaine (positively charged at physiological pH) enters dopaminergic
  synapse → binds to outward-facing DAT conformation → blocks
  reuptake → dopamine persists in synapse for minutes instead of ms
  → sustained, intense D1/D2 activation → EUPHORIA ("rush")

Simultaneously: NET blockade → norepinephrine accumulates →
  heart rate ↑, blood pressure ↑, pupils dilate (mydriasis),
  vasoconstriction (cold extremities, cardiac ischemia risk)

Step 3 — THE CRASH (30–90 min after use)
Dopamine stores in presynaptic terminals depleted (no reuptake = no recycling)
→ dopamine levels in NAc fall BELOW baseline
→ D1/D2 activation lost → dysphoria, depression, exhaustion, irritability
→ brain interprets this as punishment signal
→ craving = prediction error signal: "dopamine was high, now it's low —
   take the drug again to restore it"

Step 4 — CRAVING AND SEEKING BEHAVIOR
Prefrontal cortex (PFC) glutamate projection to NAc: in cocaine-exposed
brain, drug-associated cues (seeing a razor blade, a mirror, a person
associated with use) → conditioned cue-triggered glutamate release from
PFC → activates NAc → craving, drug-seeking behavior
(Pavlovian conditioning of reward circuits)

Step 5 — CHRONIC CHANGES (repeated use)
D2 receptor downregulation (PET scans: cocaine users show 20–30% fewer
striatal D2 receptors) → reduced ability to experience natural rewards →
anhedonia → only cocaine reliably activates reward system → escalating use
ΔFosB (transcription factor) accumulates in NAc with repeated stimulation
→ persistent changes in gene expression → long-lasting vulnerability to relapse
even after extended abstinence (explains relapse months/years later)

• Name the plant source of: (a) morphine (b) cocaine (c) THC (d) LSD
• Distinguish between addiction and physical dependence with one example each
• Explain why cocaine is both a local anesthetic and a stimulant — name two different mechanisms
• Describe the pathway by which chronic alcohol use leads to liver cirrhosis (stages)
• State three harmful effects of tobacco smoking: one due to nicotine, one due to tar, one due to CO
• What is fetal alcohol syndrome? Name three features
• Explain the neurological basis of withdrawal symptoms in opioid dependence
• Why does tolerance develop to opioids? Name the receptor mechanism

• Table 8.2 (or equivalent): Classification of drugs, plant sources, primary effects — as presented in NCERT
• Alcohol metabolism pathway (ethanol → acetaldehyde → acetate) — mentioned in NCERT text
• NCERT mentions that opioids bind to opioid receptors normally activated by endorphins — know this receptor connection
• Flow: drug use → tolerance → addiction → withdrawal — conceptual diagram from NCERT

• THC is derived from which plant?
• Name the endogenous ligand that cannabinoids mimic
• Which enzyme metabolizes ethanol to acetaldehyde?
• CO from tobacco binds hemoglobin with how many times more affinity than O₂?
• What syndrome results from thiamine deficiency in chronic alcoholics?
• Heroin is chemically known as?
• Which opioid receptor subtype mediates euphoria and analgesia (most clinically relevant)?
• Stretch: A person with ALDH2*2 (East Asian flushing gene) takes disulfiram (Antabuse — also an ALDH inhibitor) and then drinks alcohol. Predict the molecular and physiological outcome — explain why this drug is used to treat alcohol dependence.

NCERT Chapter 8 link: Human Health and Disease — Class 12 Biology Exam connections: Drug plant sources (morphine/cocaine/cannabis) appear as direct 1-mark MCQs. Alcohol liver disease stages and fetal alcohol syndrome are 2-mark descriptor questions. NEET 2022, 2023 had questions on opioid receptor type and cannabinoid plant source. Study strategy: Make a flashcard table: Drug | Class | Source | Mechanism | Key Risk. Test yourself on plant sources daily — these are pure memory items where points are easy to win.

• Use the platform-native live simulation or PhET-style tool for this topic (number line, Venn, physics playground, molecule builder, sensor dashboard, etc.).
• Mirror / body / home activity: physically do the concept (count objects, measure, role-play) and photograph or describe for portfolio.
• Voice or text reflection with AI Mentor: explain the concept to a younger student or family member.

• "Explain this concept to a Class 6 student using one real example from an Indian home, school, market, or festival."
• "What is one common mistake students make here, and how would you catch yourself making it?"
• Stretch: "How does this connect to coding, robotics, money, health, environment, or a future career?"

• Complete the core practice + one extension activity (photo, table, short reflection, or mini-project) for base XP + topic badge.
• 5-7 day streak or family discussion note = multiplier + visible artifact in parent/principal dashboard.
• Best real-world application stories (anonymised) featured on class or national leaderboard.

• One hands-on project or measurement using the Drishti kit or household items that makes the concept physical.
• Direct link to at least one Future Skill track (Money Management, Green Tech, Cyber Defenders, Micro-Entrepreneurship, AI Mastery, Sustainable Living, Personality Development).
• Coding extension where relevant (simple script, simulation, or data logging).

This material emphasises experiential "learning by doing", competency (apply/create/analyse), vocational exposure, critical thinking, and multidisciplinary connections. Designed to feed live worlds, AI Mentor (with memory), gamification, robotics, parent analytics, and future skills — not just exam prep.

Portfolio Evidence Idea: Your photo/table/reflection/project + one sentence on "How this helps me in real life or a possible future path."

Open the Practice tab for aligned questions (easy/medium/hard + case-based) with full AI scaffolding.

See curriculum for cross-links and the full future-skills/robotics chapters.